Technology | Advanced Visualization | May 11, 2018

EnvoyAI, TeraRecon and Insignia Bringing Artificial Intelligence to U.K. Customers

Integration brings AI-enhanced imaging workflows to Insignia’s InSight PACS and TeraRecon’s iNtuition advanced visualization software

EnvoyAI, TeraRecon and Insignia Bringing Artificial Intelligence to U.K. Customers

May 11, 2018 — EnvoyAI announced a new integration with Insignia Medical Systems’ InSight PACS (picture archiving and communication system) to provide artificial intelligence (AI)-enhanced imaging workflows to customers. For initial launch in the U.K., this integration provides curated AI content available on the EnvoyAI platform within the PACS environment at multiple integration points.  These include AI results viewing directly within the PACS viewer, as well as within the already established Insignia integration with TeraRecon.

The integrations with EnvoyAI and TeraRecon allow hospitals to customize their AI portfolio based on algorithms they can test and consume from within their Insignia PACS, including the utilization of each hospital’s own internally developed algorithms.

The EnvoyAI platform readies the Insignia InSight PACS for the launch of any AI application – starting with the AI content already available on the EnvoyAI Exchange.  With recent growth, the EnvoyAI Exchange now offers a total of 53 products from 22 partners, of which 10 have already achieved U.S. Food and Drug Administration (FDA) clearance. The partnership creates added potential for future workflow integrations to TeraRecon’s iNtuition advanced visualization solution already promoted by Insignia, as well as TeraRecon’s new NorthStar AI-results viewer for advanced physician interactions.

The integration will be displayed in the EnvoyAI and TeraRecon booths at the 2018 Society for Imaging Informatics in Medicine (SIIM) Annual Meeting, May 31-June 2 in National Harbor, Md.

For more information: www.terarecon.com, www.envoyai.com, www.insigniamedical.co.uk

 

Related Content

DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography. Photo by Greg Freiherr

Feature | Cardiac Imaging | March 16, 2019 | By Greg Freiherr
Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echoca
Sponsored Content | Videos | Enterprise Imaging | March 15, 2019
As a VNA, GE Healthcare Ce
Bay Labs Announces New Data on EchoGPS, AutoEF AI Software at ACC.19
News | Cardiovascular Ultrasound | March 15, 2019
Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...
FDA Grants Breakthrough Designation to Paige.AI
News | Digital Pathology | March 08, 2019
Artificial intelligence (AI) startup company Paige.AI has been granted Breakthrough Device designation by the U.S. Food...